Head-To-Head Analysis: Anteris Technologies Global (NASDAQ:AVR) vs. Inogen (NASDAQ:INGN)

Inogen (NASDAQ:INGN) and Anteris Technologies Global (NASDAQ:AVR) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, valuation, risk, institutional ownership, dividends and analyst recommendations.

Earnings and Valuation

This table compares Inogen and Anteris Technologies Global”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inogen	$315.66 million	0.95	-$102.45 million	($2.25)	-5.57
Anteris Technologies Global	N/A	N/A	N/A	N/A	N/A

Anteris Technologies Global has lower revenue, but higher earnings than Inogen.

Insider and Institutional Ownership

89.9% of Inogen shares are held by institutional investors. 1.0% of Inogen shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares Inogen and Anteris Technologies Global’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Inogen	-15.89%	-27.38%	-16.77%
Anteris Technologies Global	N/A	N/A	N/A

Analyst Recommendations

This is a summary of recent ratings for Inogen and Anteris Technologies Global, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inogen	0	2	1	0	2.33
Anteris Technologies Global	0	0	4	0	3.00

Inogen presently has a consensus target price of $7.00, suggesting a potential downside of 44.13%. Anteris Technologies Global has a consensus target price of $16.50, suggesting a potential upside of 177.31%. Given Anteris Technologies Global’s stronger consensus rating and higher probable upside, analysts clearly believe Anteris Technologies Global is more favorable than Inogen.

Summary

Anteris Technologies Global beats Inogen on 6 of the 9 factors compared between the two stocks.

About Inogen

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

About Anteris Technologies Global

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.